News Conference News TCT 2023 Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3 Michael O'Riordan November 01, 2023
News Conference News TCT 2023 Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials Michael O'Riordan October 24, 2023
News Daily News Abbott to Stop Making Trifecta Surgical Aortic Valves Michael O'Riordan July 31, 2023
News Daily News FDA Alert: Possible Early Deterioration of Abbott Trifecta SAVR Valves Todd Neale February 27, 2023